Hait and Libutti in conversation; Rutgers Cancer Institute founder and its current director talk history

Share on facebook
Share on twitter
Share on linkedin
Share on email
Share on print
Steven K. Libutti, MD, FACS

Steven K. Libutti, MD, FACS

Director, Rutgers Cancer Institute of New Jersey
Senior vice president of oncology services, RWJBarnabas Health; Vice chancellor for cancer programs, Rutgers Biomedical and Health Sciences; Professor of surgery, Rutgers Robert Wood Johnson Medical School; Affiliated Distinguished Professor in Genetics, Rutgers School of Arts and Sciences.
William N. Hait, MD, PhD

William N. Hait, MD, PhD

Global Head, Johnson & Johnson External Innovation.

In 1993, when William Hait came to New Jersey to start work toward the NCI designation for Rutgers, the place had one office and three cubicles.

Four years later, in 1997, the Cancer Institute of New Jersey received the NCI Cancer Center designation, and on the next review cycle, in 2002, it received the Comprehensive Cancer Center designation.

The Cancer History Project invited Hait, the first director of Rutgers Cancer Institute of New Jersey to sit down for a conversation with Steven K. Libutti, the institution’s current director.

“That’s almost unprecedented today, to be able to achieve that, and so, that’s an amazing accomplishment,” Libutti said to Hait.

How did Hait get it done? 

“I was given some very sound advice from my colleagues at Yale. They said, ‘Your instinct will be to build the basic science programs first.’ They said, ‘Build the clinical programs first, because that’s what the center at first will be known for.’

“So, I tried my best to recruit outstanding clinical people, clinical researchers, master clinicians, people who could really be dedicated to giving incredibly high-level care to the people in New Jersey.”

Rutgers, now a part of a health system and a scientific consortium with Princeton University, recently started construction of a $750 million cancer hospital in collaboration with RWJBarnabas Health.

Table of Contents

YOU MAY BE INTERESTED IN

Acting Director Dr. Krzysztof Ptak’s words reverberated throughout the meeting room—and the heads of several of us—during the National Cancer Institute’s Office of Cancer Centers update on the final day of the 2024 Association of American Cancer Institutes/Cancer Center Administrators Forum Annual Meeting in Chicago.
“Bridge to Bahia” exhibit.Source: Sylvester Comprehensive Cancer CenterKaren Estrada, a survivor of acute myeloid leukemia, used visual art to communicate with her two boys while undergoing a bone marrow transplant at Sylvester Comprehensive Cancer Center. Because Estrada’s treatment required isolation, and her young children could not yet read and write, she sought out other creative vessels to foster closeness between them.

Never miss an issue!

Get alerts for our award-winning coverage in your inbox.

Login